Refine by
Biotechnology Research Articles & Analysis: Older
65 news found
CD Formulation, known for its expertise in contract R&D in biotechnology, provides researchers with a full range of bespoke technical solutions. ...
STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the launch of its new Accelerated Aging Testing Services for medical device manufacturers to ensure the long-term reliability and safety of their products. The Accelerated Aging Testing utilizes high temperatures for a period of time to simulate the effects of real-time aging, ...
BySTEMart
Flavonoids are abundant in plants, contributing to their vivid colors, fragrances, and flavors. These compounds are widely researched for their antioxidant properties, making them essential in the development of health supplements and cosmetics. ...
"We invite healthcare professionals, researchers, and industry partners to explore the remarkable potential of this innovative peptide and discover how it can contribute to the advancement of diabetes management." About Creative Enzymes Creative Enzymes is a leading supplier of specialized enzyme products and services committed to advancing biotechnological ...
Creative Enzymes, a renowned biotechnology company, has unveiled a groundbreaking product that is set to revolutionize the health and wellness industry. ...
STEMart, a US-based provider of comprehensive services for all phases of medical device development, proudly announces the launch of its new Transportation and Distribution Simulation Services for the medical device industry. These enhanced services offer manufacturers a comprehensive approach to ensuring their products arrive at their destination safely and securely. Transportation and ...
BySTEMart
CD ComputaBio, a pioneering provider of computational biology services, has recently introduced its advanced Computer-Aided Drug Design (CADD) services, revolutionizing the drug discovery landscape. Through the utilization of cutting-edge computational chemistry techniques, CD ComputaBio aims to streamline and enhance the process of drug discovery for pharmaceutical companies, research ...
STEMart, a US-based provider of comprehensive services for all phases of medical device development, is proud to announce the launch of its new Pilot Production Services for the medical device industry. These services allow manufacturers to test and refine their products prior to full-scale production, streamlining the development process of new medical devices and minimizing risk to save time ...
BySTEMart
Investorideas.com (www.investorideas.com) Biotech Stock News Bites - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders made the NASDAQ Top ten percentage gainers today on news. The stock is trading at $2.0050, up $0.8750, gaining +77.0925% on volume of over 8o ...
STEMart, a US-based provider of comprehensive services for all phases of medical device development, announced the launch of its new Force Degradation Services to help pharmaceutical and medical device companies evaluate the stability of their drug candidates and finished products under a variety of stress conditions, ensuring their safety and efficacy throughout their shelf life. Forced ...
BySTEMart
CD Formulation is widely recognized for its expertise in pharmaceutical analysis and formulation services, catering to various industries, including pharmaceutical, biotechnology, and academic research. With a relentless commitment to delivering innovative solutions and excellent customer service, CD Formulation has built a strong reputation in the industry, ...
However, due to their scarcity and diversity, research in this area has been traditionally challenging, making this development a beacon of hope for patients and researchers worldwide. ...
Creative BioMart, one of the world leading biotechnology companies serving science, recently updated its R-PEAPC Conjugated Proteins offerings to meet different research needs and applications. ...
The event featured thousands of presentations on cutting-edge research, as well as numerous opportunities for networking and collaboration. ...
Frost & Sullivan recently assessed the artificial intelligence (AI)-enabled preclinical development industry, and, based on its analysis results, recognizes VeriSIM Life with the 2022 North America Competitive Strategy Leadership Award. The company's core mission is to increase human life expectancy through artificial intelligence-driven biosystem simulations and to personalize patient ...
OpenFold, a non-profit artificial intelligence (AI) research consortium whose goal is to develop free and open source software tools for biology and drug discovery, today announced the addition of four new industry members: Bayer, Dassault Systèmes, CHARM Therapeutics, and BaseCamp Research Ltd. OpenFold, a consortium of academic and industry partners ...
This combined discovery and translational engine allows pharmaceutical researchers to preflight advancements in medicine in a fraction of the time and cost it takes today, resulting in far better patient outcomes. ...
The Annual Meeting consists of cutting-edge research presentations by experts in the field, oral and poster abstract presentations, and ample opportunity for structured and informal discussions, including important networking opportunities. ...
Amerigo Scientific, a distributor focused on providing critical products and services to the biomedical and life science communities, recently announced the launch of its new polyclonal antibody to human blood coagulation factor XIII to support researchers in life science fields for the detection of blood coagulation factor XIII. This antibody is used for research only, not for human, therapeutic ...
Terray Therapeutics, a biotechnology company accelerating drug discovery through the application of computational approaches to precisely generated chemical data at scale; and Calico Life Sciences, a biotechnology organization focused on age-related interventions and founded by Alphabet and Arthur D. Levinson, today announced a research ...